OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15
Showing 15 citing articles:
Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9104-9104
Open Access | Times Cited: 15
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9104-9104
Open Access | Times Cited: 15
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
One-Pot Synthesis of 1-Thia-4-azaspiro[4.4/5]alkan-3-ones via Schiff Base: Design, Synthesis, and Apoptotic Antiproliferative Properties of Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Mohamed M. Hammouda, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 467-467
Open Access | Times Cited: 9
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Mohamed M. Hammouda, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 467-467
Open Access | Times Cited: 9
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 8
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 8
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 2
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 2
New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors
Yaser A. Mostafa, Abdeljalil Assoud, Ahmed Desoky, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Yaser A. Mostafa, Abdeljalil Assoud, Ahmed Desoky, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
A review: Biological activities of novel cyanopyridine derivatives
Yurou Wu, Tao Wu, Yong Huang
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Closed Access | Times Cited: 7
Yurou Wu, Tao Wu, Yong Huang
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Closed Access | Times Cited: 7
ANTIMICROBIAL, ANTIFUNGAL, LARVICIDAL, AND ANTIOXIDANT ACTIVITY OF FRESHLY PREPARED CYANOPYRIDINE DERIVATIVES
A. Kistan, V Kanchana, C. Esther Jeyanthi, et al.
RASAYAN Journal of Chemistry (2023) Vol. 16, Iss. 04, pp. 2171-2180
Open Access | Times Cited: 7
A. Kistan, V Kanchana, C. Esther Jeyanthi, et al.
RASAYAN Journal of Chemistry (2023) Vol. 16, Iss. 04, pp. 2171-2180
Open Access | Times Cited: 7
Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1039-1039
Open Access | Times Cited: 6
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1039-1039
Open Access | Times Cited: 6
Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity
Moataz A. Shaldam, Ahmed F. Khalil, Hadia Almahli, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access | Times Cited: 2
Moataz A. Shaldam, Ahmed F. Khalil, Hadia Almahli, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access | Times Cited: 2
Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAFV600E: Design, Synthesis, and Antiproliferative Activity
Lamya H. Al-Wahaibi, Mohamed Hisham, Hesham A. Abou‐Zied, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1522-1522
Open Access | Times Cited: 2
Lamya H. Al-Wahaibi, Mohamed Hisham, Hesham A. Abou‐Zied, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1522-1522
Open Access | Times Cited: 2
Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access
Design, synthesis, and antiproliferative activity of new 1,2,3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAFV600E inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
RSC Advances (2024) Vol. 14, Iss. 52, pp. 38403-38415
Open Access
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
RSC Advances (2024) Vol. 14, Iss. 52, pp. 38403-38415
Open Access
